One of our advocates worked with a patient matched in Atlas who was successfully enrolled in two separate free drug programs but was denied for Eliquis, treating her Atrial Fibrillation, due to a program requirement that patients must pay 3% of their annual income in prescription costs before becoming eligible. The two medications had significantly reduced patient expenditures at the pharmacy, forcing her to pay out of pocket for a few months before Atlas could submit a proper appeal to the Bristol Myers Squibb Assistance Foundation. She needed to continue even without the assistance program – Atrial Fibrillation, left untreated, can lead to dangerous complications.
 
As soon as the opportunity became available, our advocate submitted the appeal. It went through successfully – and the patient was approved for the total cost of her medication to be covered! When our advocate called to give her the great news, she shared on the phone how “delighted and thankful she was for our persistence in hanging on through this. Truly a blessing!” She is so relieved that assistance programs like this are available to her, helping her afford the care she needs.